Matches in SemOpenAlex for { <https://semopenalex.org/work/W3216508623> ?p ?o ?g. }
- W3216508623 abstract "Activation of co-stimulatory pathways in cytotoxic T lymphocytes expressing chimeric antigen receptors (CARs) have proven to boost effector activity, tumor rejection and long-term T cell persistence. When using antigen-specific T cell receptors (TCR) instead of CARs, the lack of co-stimulatory signals hampers robust antitumoral response, hence limiting clinical efficacy. In solid tumors, tumor stroma poses an additional hurdle through hindrance of infiltration and active inhibition. Our project aimed at generating chimeric co-stimulatory switch proteins (CSP) consisting of intracellular co-stimulatory domains (ICD) fused to extracellular protein domains (ECD) for which ligands are expressed in solid tumors. The ECD of CD40L was selected for combination with the ICD from the CD28 protein. With this approach, it was expected to not only provide co-stimulation and strengthen the TCR signaling, but also, through the CD40L ECD, facilitate the activation of tumor-resident antigen-presenting cells (APCs), modulate activation of tumor endothelium and induce TCR-MHC independent apoptotic effect on tumor cells. Since CD28 and CD40L belong to different classes of transmembrane proteins (type I and type II, respectively), creating a chimeric protein presented a structural and functional challenge. We present solutions to this challenge describing different CSP formats that were successfully expressed in human T cells along with an antigen-specific TCR. The level of surface expression of the CSPs depended on their distinct design and the state of T cell activation. In particular, CSPs were upregulated by TCR stimulation and downregulated following interaction with CD40 on target cells. Ligation of the CSP in the context of TCR-stimulation modulated intracellular signaling cascades and led to improved TCR-induced cytokine secretion and cytotoxicity. Moreover, the CD40L ECD exhibited activity as evidenced by effective maturation and activation of B cells and DCs. CD40L:CD28 CSPs are a new type of switch proteins designed to exert dual beneficial antitumor effect by acting directly on the gene-modified T cells and simultaneously on tumor cells and tumor-supporting cells of the TME. The observed effects suggest that they constitute a promising tool to be included in the engineering process of T cells to endow them with complementary features for improved performance in the tumor milieu." @default.
- W3216508623 created "2021-12-06" @default.
- W3216508623 creator A5002943706 @default.
- W3216508623 creator A5011167396 @default.
- W3216508623 creator A5027519283 @default.
- W3216508623 creator A5030518549 @default.
- W3216508623 creator A5080949843 @default.
- W3216508623 date "2021-11-29" @default.
- W3216508623 modified "2023-10-02" @default.
- W3216508623 title "Double Strike Approach for Tumor Attack: Engineering T Cells Using a CD40L:CD28 Chimeric Co-Stimulatory Switch Protein for Enhanced Tumor Targeting in Adoptive Cell Therapy" @default.
- W3216508623 cites W1644827081 @default.
- W3216508623 cites W1653477942 @default.
- W3216508623 cites W1859254390 @default.
- W3216508623 cites W1955557233 @default.
- W3216508623 cites W1964181260 @default.
- W3216508623 cites W1964788867 @default.
- W3216508623 cites W1973101373 @default.
- W3216508623 cites W1973122969 @default.
- W3216508623 cites W1981221499 @default.
- W3216508623 cites W1981400650 @default.
- W3216508623 cites W1983297411 @default.
- W3216508623 cites W1989873812 @default.
- W3216508623 cites W1996603186 @default.
- W3216508623 cites W1997981530 @default.
- W3216508623 cites W2003107403 @default.
- W3216508623 cites W2004720857 @default.
- W3216508623 cites W2017390384 @default.
- W3216508623 cites W2024981673 @default.
- W3216508623 cites W2027005522 @default.
- W3216508623 cites W2027554407 @default.
- W3216508623 cites W2030029123 @default.
- W3216508623 cites W2031462618 @default.
- W3216508623 cites W2034359690 @default.
- W3216508623 cites W2037683223 @default.
- W3216508623 cites W2039128883 @default.
- W3216508623 cites W2040468807 @default.
- W3216508623 cites W2042765435 @default.
- W3216508623 cites W2043991982 @default.
- W3216508623 cites W2046664795 @default.
- W3216508623 cites W2047269521 @default.
- W3216508623 cites W2050698267 @default.
- W3216508623 cites W2051949323 @default.
- W3216508623 cites W2055248228 @default.
- W3216508623 cites W2059689009 @default.
- W3216508623 cites W2074801788 @default.
- W3216508623 cites W2080604217 @default.
- W3216508623 cites W2085939052 @default.
- W3216508623 cites W2089097951 @default.
- W3216508623 cites W2095434093 @default.
- W3216508623 cites W2101099967 @default.
- W3216508623 cites W2102741019 @default.
- W3216508623 cites W2108271312 @default.
- W3216508623 cites W2109503169 @default.
- W3216508623 cites W2115278843 @default.
- W3216508623 cites W2115356035 @default.
- W3216508623 cites W2119014335 @default.
- W3216508623 cites W2122144555 @default.
- W3216508623 cites W2124053776 @default.
- W3216508623 cites W2130201220 @default.
- W3216508623 cites W2130473166 @default.
- W3216508623 cites W2142711009 @default.
- W3216508623 cites W2146059841 @default.
- W3216508623 cites W2159115760 @default.
- W3216508623 cites W2166811800 @default.
- W3216508623 cites W2301169192 @default.
- W3216508623 cites W2416840104 @default.
- W3216508623 cites W2514449559 @default.
- W3216508623 cites W2514996992 @default.
- W3216508623 cites W2519381080 @default.
- W3216508623 cites W2559593455 @default.
- W3216508623 cites W2582686270 @default.
- W3216508623 cites W2592666036 @default.
- W3216508623 cites W2593327310 @default.
- W3216508623 cites W2620138444 @default.
- W3216508623 cites W2766547496 @default.
- W3216508623 cites W2786055362 @default.
- W3216508623 cites W2805603674 @default.
- W3216508623 cites W2897324861 @default.
- W3216508623 cites W2902543138 @default.
- W3216508623 cites W2911867856 @default.
- W3216508623 cites W2922068441 @default.
- W3216508623 cites W2946717294 @default.
- W3216508623 cites W2972693830 @default.
- W3216508623 cites W2995900562 @default.
- W3216508623 cites W2997652717 @default.
- W3216508623 cites W3003130062 @default.
- W3216508623 cites W3036066280 @default.
- W3216508623 cites W3082381897 @default.
- W3216508623 cites W3104085757 @default.
- W3216508623 cites W3164930583 @default.
- W3216508623 cites W3168169234 @default.
- W3216508623 cites W3176945324 @default.
- W3216508623 cites W3179304282 @default.
- W3216508623 cites W3188235617 @default.
- W3216508623 cites W3201145014 @default.
- W3216508623 cites W4210637293 @default.
- W3216508623 cites W4294138012 @default.
- W3216508623 doi "https://doi.org/10.3389/fimmu.2021.750478" @default.
- W3216508623 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34912334" @default.
- W3216508623 hasPublicationYear "2021" @default.